Dudediligence.

Apogee Therapeutics, Inc

APGENASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$171.2M

19 notices · 2,188,285 sh

Oct 2025 to Oct 2026

Reported ·

$169.8M

79 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

78 of 79 reported sales carry the 10b5-1 box.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-07-01: CARL DAMBKOWSKI, Form 1442026-06-22: CARL DAMBKOWSKI, Form 1442026-06-22: HENDERSON MICHAEL THOMAS, Form 1442026-05-13: HENDERSON MICHAEL THOMAS, Form 1442026-05-06: CARL DAMBKOWSKI, Form 1442026-05-01: JANE HENDERSON, Form 1442026-03-25: JANE HENDERSON, Form 1442026-02-11: HENDERSON MICHAEL THOMAS, Form 1442026-01-22: Fairmount Healthcare Fund II L.P., Form 1442026-01-07: CARL DAMBKOWSKI, Form 1442026-01-02: JANE HENDERSON, Form 1442025-12-19: JANE HENDERSON, Form 1442025-12-04: JANE HENDERSON, Form 1442025-12-04: CARL DAMBKOWSKI, Form 1442025-11-25: JANE HENDERSON, Form 1442025-11-14: JANE HENDERSON, Form 1442025-11-13: HENDERSON MICHAEL THOMAS, Form 1442025-11-11: JANE HENDERSON, Form 1442025-11-05: CARL DAMBKOWSKI, Form 1442025-11-05: Dambkowski Carl, sold2025-11-11: Henderson Jane, sold2025-11-13: HENDERSON MICHAEL THOMAS, sold2025-11-14: Henderson Jane, sold2025-11-25: Henderson Jane, sold2025-12-04: HENDERSON MICHAEL THOMAS, sold2025-12-04: Henderson Jane, sold2025-12-04: Dambkowski Carl, sold2025-12-10: HENDERSON MICHAEL THOMAS, sold2025-12-19: Henderson Jane, sold2026-01-02: Henderson Jane, sold2026-01-07: Dambkowski Carl, sold2026-01-14: HENDERSON MICHAEL THOMAS, sold2026-01-22: Harwin Peter Evan, sold2026-02-02: Henderson Jane, sold2026-02-04: Dambkowski Carl, sold2026-02-11: HENDERSON MICHAEL THOMAS, sold2026-03-02: Henderson Jane, sold2026-03-04: Dambkowski Carl, sold2026-03-11: HENDERSON MICHAEL THOMAS, sold2026-03-25: Henderson Jane, sold2026-04-01: Henderson Jane, sold2026-04-01: Dambkowski Carl, sold2026-04-08: HENDERSON MICHAEL THOMAS, sold2026-04-16: Henderson Jane, sold2026-05-01: Henderson Jane, sold2026-05-06: Dambkowski Carl, sold2026-05-13: HENDERSON MICHAEL THOMAS, sold2026-06-03: Dambkowski Carl, sold2026-06-10: HENDERSON MICHAEL THOMAS, sold2026-06-22: HENDERSON MICHAEL THOMAS, sold2026-06-22: Dambkowski Carl, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-07-01CARL DAMBKOWSKI, Chief Medical Officer$2,190,045
16,500 shplan 2025-09-22Form 4s on file end Jun 23144 ↗
2026-06-22CARL DAMBKOWSKI, Chief Medical Officer$1,391,852
15,400 shplan 2025-09-22144 ↗
Form 4, 2026-06-24: sold 26,400 at $132.60 Form 4 ↗
2026-06-22HENDERSON MICHAEL THOMAS, Chief Executive Officer$10.6M
80,000 shplan 2025-08-13144 ↗
Form 4, 2026-06-24: sold 80,000 at $132.54 Form 4 ↗
2026-05-13HENDERSON MICHAEL THOMAS, Chief Executive Officer$4,948,200
60,000 shplan 2025-08-13144 ↗
Form 4, 2026-05-15: sold 20,000 at $82.09 Form 4 ↗
2026-05-06CARL DAMBKOWSKI, Chief Medical Officer$1,832,380
22,000 shplan 2025-09-22144 ↗
Form 4, 2026-05-08: sold 5,500 at $84.14 Form 4 ↗
2026-05-01JANE HENDERSON, Chief Financial Officer$165,780
2,000 shplan 2025-09-02144 ↗
Form 4, 2026-05-04: sold 2,000 at $82.04 Form 4 ↗
2026-03-25JANE HENDERSON, Chief Financial Officer$438,000
6,000 shplan 2025-09-02144 ↗
Form 4, 2026-03-27: sold 2,000 at $85.00 Form 4 ↗
2026-02-11HENDERSON MICHAEL THOMAS, Chief Executive Officer$3,840,000
60,000 shplan 2025-08-13144 ↗
Form 4, 2026-02-13: sold 20,000 at $63.35 Form 4 ↗
2026-01-22Fairmount Healthcare Fund II L.P., Director$133.5M
1,750,000 shno plan date144 ↗
Form 4, 2026-01-22: sold 1,750,000 at $76.30 Form 4 ↗
2026-01-07CARL DAMBKOWSKI, Chief Medical Officer$2,754,400
35,200 shplan 2025-09-22144 ↗
Form 4, 2026-01-09: sold 18,700 at $77.84 Form 4 ↗
2026-01-02JANE HENDERSON, Chief Financial Officer$905,760
12,000 shplan 2025-09-02144 ↗
Form 4, 2026-01-06: sold 8,000 at $76.14 Form 4 ↗
2025-12-19JANE HENDERSON, Chief Financial Officer$116,025
1,500 shplan 2024-09-27144 ↗
Form 4, 2025-12-23: sold 1,500 at $80.00 Form 4 ↗
2025-12-04JANE HENDERSON, Chief Financial Officer$111,825
1,500 shplan 2024-09-27144 ↗
Form 4, 2025-12-05: sold 1,500 at $75.00 Form 4 ↗
2025-12-04CARL DAMBKOWSKI, Chief Medical Officer$812,595
10,900 shplan 2024-08-21144 ↗
Form 4, 2025-12-05: sold 10,900 at $75.00 Form 4 ↗
2025-11-25JANE HENDERSON, Chief Financial Officer$101,775
1,500 shplan 2024-09-27144 ↗
Form 4, 2025-11-28: sold 1,500 at $70.00 Form 4 ↗
2025-11-14JANE HENDERSON, Chief Financial Officer$125,940
2,000 shplan 2024-09-27144 ↗
Form 4, 2025-11-14: sold 2,000 at $65.00 Form 4 ↗
2025-11-13HENDERSON MICHAEL THOMAS, Chief Executive Officer$6,697,800
100,000 shplan 2025-08-13144 ↗
Form 4, 2025-11-13: sold 20,000 at $63.01 Form 4 ↗
2025-11-11JANE HENDERSON, Chief Financial Officer$56,770
1,000 shplan 2024-09-27144 ↗
Form 4, 2025-11-13: sold 1,000 at $60.00 Form 4 ↗
2025-11-05CARL DAMBKOWSKI, Chief Medical Officer$581,312
10,785 shplan 2024-08-21144 ↗
Form 4, 2025-11-07: sold 10,785 at $55.07 Form 4 ↗